Dopacone 150/37.5 200 mg tablet

Dopacone 150/37.5/200 mg tablet is a combination drug, which contains three ingredients: Levodopa (150 mg), Carbidopa (37.5 mg), and Entacapone (200 mg).

Levodopa (150 mg): Converts to dopamine in the brain to help regulate body movement.
Carbidopa (37.5 mg): Prevents the breakdown of levodopa inside the body before it enters the brain.
Entacapone (200 mg): Increases the effectiveness and prolongs the activity of levodopa.

Control tremor, stiffness of DOPACONE 150/37.5 MG muscles and bradykinesia.
Replace separate doses of carbidopa, levodopa, and entacapone.
Used for “wearing-off” symptoms, when previously taken medications become less effective between doses.

Uncontrolled movements (dyskinesia)
Nausea and diarrhea
Innocent change in the color of urine (chromaturia)
Dizziness and orthostatic hypotension.

Dopacone 150/37.5/200 mg tablet IN PAKISTAN  is a combination medicine, which is used to treat patients with Parkinson’s disease and to relieve “wearing-off” symptoms as well as improve motor activity.

There is no “perfect” medicine to be used for the treatment of Parkinson’s disease. The therapy is highly personalized; however, Carbidopa-Levodopa (Sinemet) is a world-known gold standard in order to treat motor symptoms by replenishing brain dopamine levels with the use of this tablet. There are other efficient tablets such as dopamine agonists (Pramipexole) and MAO-B inhibitors (Rasagiline).